HIGHLIGHTS
- who: Kelen Alvarez and colleagues from the University of Sao Paulo, Sao Paulo, Brazil have published the Article: Preclinical Evaluation of the Tumorigenic and Immunomodulatory Properties of Human Bone Marrow Mesenchymal Stromal Cell Populations with Clonal Trisomy 5, in the Journal: Stem Cells International of 19/08/2022
- what: The authors report an ensuing exploratory preclinical evaluation of these MSC products with clonal trisomy 5 regarding their oncogenic and immunomodulatory potential.
- how: This result was verified either with injections of MSC harboring trisomy 5 (MSC samples T5-50 or T5-53) or with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.